<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39365354</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1536-4798</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>04</Day></PubDate></JournalIssue><Title>Cornea</Title><ISOAbbreviation>Cornea</ISOAbbreviation></Journal><ArticleTitle>Effects of the COVID-19 Pandemic on Microbial Keratitis: A 5-Year Comparative Study.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1097/ICO.0000000000003720</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To report the clinical and microbiological profiles of microbial keratitis and its antimicrobial resistance before, during, and after COVID-19.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This was a retrospective case-note review of all corneal scrape specimens collected from patients with microbial keratitis from January 2018 to December 2023. Case records were analyzed for demographic characteristics, microbiological diagnosis, and antibiograms. All outcome variables were collected, stratified, and compared between 3 periods: the pre-COVID-19 group (January-December 2019), the COVID-19 group (January 2020-December 2022), and the post-COVID-19 group (January-December 2023).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 947 corneal cultures from 947 patients were reviewed. Gram-positive bacteria predominated in all periods, with no significant differences in their distribution. Staphylococcus epidermidis was the most frequently identified organism. Pseudomonas aeruginosa was the most common Gram-negative bacterium, with its incidence significantly lower in the post-COVID period. Fungal infections showed a significant increase in the post-COVID group, with Fusarium sp. being the most common fungus and showing a significant increase in incidence in the post-COVID group.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Despite a stable incidence of microbial keratitis, this study highlights a concerning trend in antibiotic resistance. Although some pathogens became less common, those that persisted have become increasingly difficult to treat. Understanding the clinical and microbiological profiles of microbial keratitis and antimicrobial resistance patterns before and after the COVID-19 pandemic is crucial for informed treatment decisions.</AbstractText><CopyrightInformation>Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Haro-Morlett</LastName><ForeName>Luis</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-4272-6497</Identifier><AffiliationInfo><Affiliation>Instituto de Oftalmologia Fundacion Conde de Valenciana, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vera-Duarte</LastName><ForeName>Guillermo Raul</ForeName><Initials>GR</Initials><Identifier Source="ORCID">0000-0002-3417-256</Identifier></Author><Author ValidYN="Y"><LastName>Oliveros-Valdes</LastName><ForeName>Francisco</ForeName><Initials>F</Initials><Identifier Source="ORCID">0009-0000-4085-4906</Identifier></Author><Author ValidYN="Y"><LastName>Cortes-Moreno</LastName><ForeName>Thelma Noemi</ForeName><Initials>TN</Initials><Identifier Source="ORCID">0009-0008-8422-8833</Identifier></Author><Author ValidYN="Y"><LastName>Ramirez-Miranda</LastName><ForeName>Arturo</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-6419-5116</Identifier></Author><Author ValidYN="Y"><LastName>Navas</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9417-5711</Identifier></Author><Author ValidYN="Y"><LastName>Graue-Hernandez</LastName><ForeName>Enrique O</ForeName><Initials>EO</Initials><Identifier Source="ORCID">0000-0003-3267-3915</Identifier></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cornea</MedlineTA><NlmUniqueID>8216186</NlmUniqueID><ISSNLinking>0277-3740</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CoiStatement>There is no conflict of interest. There is no funding received.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>11</Hour><Minute>5</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39365354</ArticleId><ArticleId IdType="doi">10.1097/ICO.0000000000003720</ArticleId><ArticleId IdType="pii">00003226-990000000-00706</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Austin A, Lietman T, Rose-Nussbaumer J. Update on the management of infectious keratitis. Ophthalmology. 2017;124:1678–1689.</Citation></Reference><Reference><Citation>Schallhorn JM, Schallhorn SC, Hettinger K, et al. Infectious keratitis after laser vision correction: incidence and risk factors. J Cataract Refract Surg. 2017;43:473–479.</Citation></Reference><Reference><Citation>Ting DSJ, Ho CS, Deshmukh R, et al. Infectious keratitis: an update on epidemiology, causative microorganisms, risk factors, and antimicrobial resistance. Eye. 2021;35:1084–1101.</Citation></Reference><Reference><Citation>Cabrera-Aguas M, Khoo P, Watson SL. Infectious keratitis: a review. Clin Exp Ophthalmol. 2022;50:543–562.</Citation></Reference><Reference><Citation>Durand ML, Barshak MB, Chodosh J. Infectious Keratitis in 2021. JAMA. 2021;326:1319–1320.</Citation></Reference><Reference><Citation>Ting DSJ, Ho CS, Cairns J, et al. 12-year analysis of incidence, microbiological profiles and in vitro antimicrobial susceptibility of infectious keratitis: the nottingham infectious keratitis study. Br J Ophthalmol. 2021;105:328–333.</Citation></Reference><Reference><Citation>Ting DSJ, Settle C, Morgan SJ, et al. A 10-year analysis of microbiological profiles of microbial keratitis: the north east england study. Eye. 2018;32:1416–1417.</Citation></Reference><Reference><Citation>Michaels L, Richardson J, Walkden A, et al. Impact of the COVID-19 pandemic on the incidence and characteristics of culture-positive microbial keratitis at a tertiary eye hospital in the UK. Clin Ophthalmol. 2022;16:2513–2519.</Citation></Reference><Reference><Citation>Chen L, Deng C, Chen X, et al. Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in wuhan, china: across sectional study. Acta Ophthalmol. 2020;98:e951–e959.</Citation></Reference><Reference><Citation>Nasiri N, Sharifi H, Bazrafshan A, et al. Ocular manifestations of COVID-19: a systematic review and meta-analysis. J Ophthalmic Vis Res. 2021;16:103–112.</Citation></Reference><Reference><Citation>Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta biomed. 2020;91:157–160.</Citation></Reference><Reference><Citation>Mexico S de S de la C de. Acuerdo 02-01RE-2022. Secretaria de Salud de la Ciudad de Mexico. Available at: https://salud.cdmx.gob.mx/acuerdos/acuerdo-02-01re-2022. Accessed June 3, 2024.</Citation></Reference><Reference><Citation>Kazemioula G, Golestani S, Alavi SMA, et al. Prevalence of self-medication during COVID-19 pandemic: a systematic review and meta-analysis. Front Public Health. 2022;10:1041695.</Citation></Reference><Reference><Citation>Hernandez-Camarena JC, Graue-Hernandez EO, Ortiz-Casas M, et al. Trends in microbiological and antibiotic sensitivity patterns in infectious keratitis: 10-year experience in mexico city. Cornea. 2015;34:778–785.</Citation></Reference><Reference><Citation>Bertoli F, Veritti D, Danese C, et al. Ocular findings in COVID-19 patients: a review of direct manifestations and indirect effects on the eye. J Ophthalmol. 2020;2020:4827304–4827309.</Citation></Reference><Reference><Citation>Moshirfar M, West WB, Marx DP. Face mask-associated ocular irritation and dryness. Ophthalmol Ther. 2020;9:397–400.</Citation></Reference><Reference><Citation>Tang YF, Chong EWT. Face mask-associated recurrent corneal erosion syndrome and corneal infection. Eye Contact Lens. 2021;47:573–574.</Citation></Reference><Reference><Citation>Burgos-Blasco B, Arriola-Villalobos P, Fernandez-Vigo JI, et al. Face mask use and effects on the ocular surface health: a comprehensive review. Ocul Surf. 2023;27:56–66.</Citation></Reference><Reference><Citation>Lai AY-K, Sit SM-M, Wu SY-D, et al. Associations of delay in doctor consultation with COVID-19 related fear, attention to information, and fact-checking. Front Public Health. 2021;9:797814.</Citation></Reference><Reference><Citation>Colchero MA, Gómez R, Figueroa JL, et al. Aumento en la oferta de consultorios adyacentes a farmacias y atencion en servicios publicos en Mexico entre 2012 y 2018. Salud publica de Mexico. 2020;62:851–858.</Citation></Reference><Reference><Citation>Audi A, AlIbrahim M, Kaddoura M, et al. Seasonality of respiratory viral infections: will COVID-19 follow suit? Front Public Health. 2020;8:567184.</Citation></Reference><Reference><Citation>Choi HG, Kim SY, Baek SU. Changes in mean and variance of ophthalmic disease incidences during COVID-19 pandemic in korea. Sci Rep. 2022;12:20364.</Citation></Reference><Reference><Citation>H Fortes B, D Tailor P, T Xu T, et al. Clinical characteristics and outcomes of endophthalmitis before and during the COVID-19 pandemic. J Ophthalmic Vis Res. 2023;18:289–296.</Citation></Reference><Reference><Citation>Ordoñez-González I, Basurto MA. La atencion primaria a la salud durante la pandemia COVID-19 en mexico. Revista Medica Del Instituto Mexicano Del Seguro Soc. 2023;61:509–515.</Citation></Reference><Reference><Citation>Lakhundi S, Siddiqui R, Khan NA. Pathogenesis of microbial keratitis. Microb Pathog. 2017;104:97–109.</Citation></Reference><Reference><Citation>Ruiz J. Enhanced antibiotic resistance as a collateral COVID-19 pandemic effect? J Hosp Infect. 2021;107:114–115.</Citation></Reference><Reference><Citation>Lynch C, Mahida N, Gray J. Antimicrobial stewardship: a COVID casualty? J Hosp Infect. 2020;106:401–403.</Citation></Reference><Reference><Citation>Getahun H, Smith I, Trivedi K, et al. Tackling antimicrobial resistance in the COVID-19 pandemic. Bull World Health Organ. 2020;98:442–442A.</Citation></Reference><Reference><Citation>Lai C-C, Chen S-Y, Ko W-C, et al. Increased antimicrobial resistance during the COVID-19 pandemic. Int J Antimicrob Agents. 2021;57:106324.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>